397 related articles for article (PubMed ID: 11585867)
21. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine.
Verhaar MJ; Keep PA; Hawkins RE; Robson L; Casey JL; Pedley B; Boden JA; Begent RH; Chester KA
J Nucl Med; 1996 May; 37(5):868-72. PubMed ID: 8965166
[TBL] [Abstract][Full Text] [Related]
24. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
25. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Schlom J
Cancer Res; 1992 Jun; 52(12):3402-8. PubMed ID: 1596900
[TBL] [Abstract][Full Text] [Related]
26. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
27. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
[TBL] [Abstract][Full Text] [Related]
28. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
30. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
[TBL] [Abstract][Full Text] [Related]
31. Single-chain antibodies in pancreatic cancer.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.
Yoo TM; Chang HK; Choi CW; Webber KO; Le N; Kim IS; Eckelman WC; Pastan I; Carrasquillo JA; Paik CH
J Nucl Med; 1997 Feb; 38(2):294-300. PubMed ID: 9025758
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
[TBL] [Abstract][Full Text] [Related]
34. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
35. [Characterization of a panel of mouse single-chain antibodies against recombinant human interferon beta1b].
Pavlova MV; Nikolaev IuS; Irodov DM; Okunev OV; Kordium VA; Gil'chuk PV
Tsitol Genet; 2008; 42(4):3-11. PubMed ID: 19140425
[TBL] [Abstract][Full Text] [Related]
36. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
37. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
38. A CDR-grafted (humanized) domain-deleted antitumor antibody.
Slavin-Chiorini DC; Kashmiri SV; Lee HS; Milenic DE; Poole DJ; Bernon E; Schlom J; Hand PH
Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481
[TBL] [Abstract][Full Text] [Related]
39. Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.
Gooden CS; Snook DE; Maraveyas A; Rowlinson-Busza G; Peters AM; Epenetos AA
J Nucl Med; 1995 May; 36(5):842-9. PubMed ID: 7738662
[TBL] [Abstract][Full Text] [Related]
40. Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma.
Otsuji E; Matsumura H; Okamoto K; Toma A; Kuriu Y; Ichikawa D; Hagiwara A; Yamagishi H
J Surg Oncol; 2003 Nov; 84(3):160-5. PubMed ID: 14598360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]